L01F Monoclonal antibodies and antibody drug conjugates Monoclonal antibodies and antibody drug conjugates Monoclonal antibodies and antibody drug conjugates Monoclonal antibodies and antibody drug conjugates L3
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L3 · Search this class · Consumer categories
Child classes
L01FACD20 (clusters of differentiation 20) inhibitors CD20 (clusters of differentiation 20) inhibitors CD20 (clusters of differentiation 20) inhibitors CD20 (clusters of differentiation 20) inhibitorsL01FBCD22 (clusters of differentiation 22) inhibitors CD22 (clusters of differentiation 22) inhibitors CD22 (clusters of differentiation 22) inhibitors CD22 (clusters of differentiation 22) inhibitorsL01FCCD38 (clusters of differentiation 38) inhibitors CD38 (clusters of differentiation 38) inhibitors CD38 (clusters of differentiation 38) inhibitors CD38 (clusters of differentiation 38) inhibitorsL01FDHER2 (human epidermal growth factor receptor 2) inhibitors HER2 (human epidermal growth factor receptor 2) inhibitors HER2 (human epidermal growth factor receptor 2) inhibitors HER2 (human epidermal growth factor receptor 2) inhibitorsL01FEEGFR (epidermal growth factor receptor) inhibitors EGFR (epidermal growth factor receptor) inhibitors EGFR (epidermal growth factor receptor) inhibitors EGFR (epidermal growth factor receptor) inhibitorsL01FFPD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitorsL01FGVEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitorsL01FXOther monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates
Active ingredients in this class
95 active ingredients 95 principios activos 95 个活性成分 95 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
- 伊尼妥单抗
L01FDactiveCN - 佐妥昔单抗
L01FXactiveCN - 依沃西单抗
L01FXactiveCN - 信迪利单抗
L01FFactiveCN - Rituximab
L01FA01withdrawnMX·EUdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·MX·HK - 卡度尼利单抗
L01FFactiveCN - 卡瑞利珠单抗
L01FFactiveCN - Amivantamab
L01FX18activeUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - 埃纳妥单抗
L01FXactiveCN - 塔奎妥单抗
L01FXactiveCN - 塔戈利单抗
L01FFactiveCN - Inotuzumab Ozogamicin
L01FB01activeUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - Obinutuzumab
L01FA03activeUS·GB·CA·AU·SG·CN·ES·TW·EUunknownAU·HK - Pembrolizumab
L01FF02withdrawnESdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - Pertuzumab
L01FD02discontinuedESactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·MX·HK - 德曲妥珠单抗
L01FDactiveCN - 恩朗苏拜单抗
L01FFactiveCN - 戈沙妥珠单抗
L01FXactiveCN - 斯鲁利单抗
L01FFactiveCN - 普特利单抗
L01FFactiveCN - Trastuzumab
L01FD01discontinuedES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK·EU - Tislelizumab
L01FF09withdrawnEUactiveUS·GB·CA·AU·SG·CN·ES·TW·EUunknownAU·HK - 格菲妥单抗
L01FAactiveCN - 泽贝妥单抗
L01FAactiveCN - Toripalimab
L01FF13activeUS·GB·CA·AU·SG·CN·ES·EUunknownAU·HK - 特立妥单抗
L01FXactiveCN - 瑞帕妥单抗
L01FAactiveCN - 索卡佐利单抗
L01FFactiveCN - 索米妥昔单抗
L01FXactiveCN - Nivolumab
L01FF01withdrawnEUdiscontinuedES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - 维恩妥尤单抗
L01FXactiveCN - 维泊妥珠单抗
L01FXactiveCN - 罗普司亭N01
L01FESalt form: 西妥昔单抗N01activeCN - 舒格利单抗
L01FFactiveCN - 艾帕洛利托沃瑞利单抗
L01FFactiveCN - 艾沙妥昔单抗
L01FCactiveCN - 芦康沙妥珠单抗
L01FXactiveCN - 莫妥珠单抗
L01FXactiveCN - 莫格利珠单抗
L01FXactiveCN - 菲诺利单抗
L01FFactiveCN - Cetuximab
L01FE01activeUS·GB·CA·AU·SG·CN·ES·TW·EUunknownAU·MX·HK - 西妥昔单抗β
L01FEactiveCN - Bevacizumab
L01FG01withdrawnES·EUdiscontinuedES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK·EU - 贝莫苏拜单抗
L01FFactiveCN - 达雷妥尤单抗
L01FCactiveCN - 那西妥单抗
L01FXactiveCN - 阿得贝利单抗
L01FFactiveCN - Atezolizumab
L01FF05discontinuedES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - Ramucirumab
L01FG02discontinuedES·MXactiveUS·GB·CA·SG·CN·ES·TW·EUunknownHK - Avelumab
L01FF04discontinuedMXactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Belantamab Mafodotin
L01FX15withdrawnESactiveUS·GB·CA·ES·TW·EUunknownAU·HK·EU - Blinatumomab
L01FX07activeGB·CA·AU·SG·ES·TW·EUunknownAU·HK - Brentuximab Vedotin
L01FX05discontinuedESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Catumaxomab
L01FX03withdrawnEUdiscontinuedCA·ESactiveGB·EU - Cemiplimab
L01FF06discontinuedCA·ESactiveUS·GB·CA·AU·ES·MX·TW·EUunknownAU - Daratumumab
L01FC01discontinuedESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Datopotamab Deruxtecan
L01FX35discontinuedESactiveUS·SG·MX·TW·EUunknownAU·HK - Dinutuximab
L01FX06withdrawnEUactiveUS·CA - Dinutuximab Beta
L01FX06activeGB·ES·TW·EUunknownAU·HK - Dostarlimab
L01FF07activeUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Durvalumab
L01FF03discontinuedMXactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Elotuzumab
L01FX08discontinuedCAactiveUS·GB·AU·ES·TW·EUunknownAU·HK - Elranatamab
L01FX32activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Enfortumab Vedotin
L01FX13discontinuedESactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Epcoritamab
L01FX27activeUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Gemtuzumab Ozogamicin
L01FX02activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK·EU - Glofitamab
L01FX28activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Ipilimumab
L01FX04discontinuedESactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Isatuximab
L01FC02discontinuedESactiveUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Linvoseltamab
L01FXdiscontinuedESactiveUS·EU - Loncastuximab Tesirine
L01FX22discontinuedESactiveUS·GB·CA·SG·TW·EUunknownAU·HK - Margetuximab
L01FD06activeUS - Mirvetuximab Soravtansine
L01FX26activeUS·GB·CA·SG·ES·TW·EUunknownAU - Mogamulizumab
L01FX09activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU - Mosunetuzumab
L01FX25discontinuedESactiveUS·GB·CA·SG·ES·TW·EUunknownHK - Naxitamab
L01FX21activeUSunknownHK - Necitumumab
L01FE03withdrawnESdiscontinuedCA·MXactiveGBunknownEU - Odronextamab
L01FX34discontinuedESactiveEU - Olaratumab
L01FX10withdrawnEUdiscontinuedCAactiveGB - Panitumumab
L01FE02discontinuedMXactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK
Show all 95 (currently showing 80) Mostrar los 95 (ahora se muestran 80) 显示全部 95 个(当前显示前 80 个) 顯示全部 95 個(目前顯示前 80 個)
- Polatuzumab Vedotin
L01FX14discontinuedESactiveUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Retifanlimab
L01FF10discontinuedESactiveUS·CA·EU - Sacituzumab Govitecan
L01FX17activeUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Serplulimab
L01FF12activeGB·SG·ES·EUunknownHK - Sugemalimab
L01FF11discontinuedESactiveMX·EU - Tafasitamab
L01FX12activeUS·GB·CA·AU·ES·TW·EUunknownAU·HK - Talquetamab
L01FX29activeUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Tarlatamab
L01FX33discontinuedESactiveGB·CA·SG·TW·EUunknownAU·HK - Teclistamab
L01FX24activeUS·GB·CA·SG·ES·TW·EUunknownAU·HK - Tisotumab Vedotin
L01FX23discontinuedESactiveUS·GB·EUunknownHK - Trastuzumab Deruxtecan
L01FD04activeUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Trastuzumab Emtansine
L01FD03activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·MX·HK - Tremelimumab
L01FX20withdrawnEUactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Zanidatamab
L01FD07discontinuedESactiveUS·GB·CA·EU - Zolbetuximab
L01FX31discontinuedESactiveUS·GB·CA·SG·TW·EUunknownAU·HK
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.